On November 7, 2023, a disciplinary panel of the Texas Medical Board temporarily restricted, with notice, the Texas medical license of Michael Pierre Zeitlin, M.D., (Lic. No. H7262) after determining his continuation in the unrestricted practice of medicine poses a continuing threat to public welfare. The restriction was effective immediately.
Dr. Zeitlin is prohibited from prescribing, administering, or dispensing Schedule II controlled substances in Texas other than a prescription written to him by a licensed provider for personal use. Dr. Zeitlin shall not use his Texas license in any jurisdiction to diagnose, treat, or prescribe controlled substances to patients in Texas for chronic or post-surgical, post-procedure, persistent non-chronic pain as defined in Board rules, or engage in the practice of pain management. Additionally, Dr. Zeitlin shall not be permitted to supervise or delegate prescriptive authority to a physician assistant or advanced practice nurse or supervise a surgical assistant.
The Board panel found that Dr. Zeitlin nontherapeutically prescribed controlled substances to 15 patients and violated the applicable standard of care and Board rules relating to the treatment of chronic pain.
The temporary restriction remains in place until the Board takes further action.